FDA NDC Directory · JSON-LD · Markdown

SAPHNELO

NDC 0310-3040 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameAnifrolumab-fnia
Labeler / ManufacturerAstraZeneca Pharmaceuticals LP
Marketing categoryBiologic License Application · App BLA761123
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsANIFROLUMAB (300 mg/2mL)
Marketing started20210730
Package count1

External sources

Source: openFDA. Public-domain (CC0).